Evidence map›Paper›PMID 37512795›Full record

ArticleMicroorganisms2023

Comparative Genomic Analysis of ST131 Subclade C2 of ESBL-Producing

Daniel Jaén-Luchoro, Arezou Kahnamouei, Shora Yazdanshenas, Anna Lindblom, Emma Samuelsson, Christina Åhrén, Nahid Karami

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Virulence · 2026
    Review
  2. Article
  3. Origin and development of twoMicrobial genomics · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Daniel Jaén-LuchoroInstitute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, 40530 Gothenburg, Sweden.ORCID 0000-0002-5988-6227
Arezou KahnamoueiDepartment of Life Sciences and Systems Biology, University of Turin, 10124 Turin, Italy.
Shora YazdanshenasSahlgrenska University Hospital, Department of Clinical Microbiology, Region Västra Götaland, 41345 Gothenburg, Sweden.
Anna LindblomInstitute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, 40530 Gothenburg, Sweden.
Emma SamuelssonSahlgrenska University Hospital, Department of Clinical Genetics and Genomics, Region Västra Götaland, 41345 Gothenburg, Sweden.
Christina ÅhrénInstitute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, 40530 Gothenburg, Sweden.
Nahid KaramiInstitute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, 40530 Gothenburg, Sweden.ORCID 0000-0002-1590-9829
Sahlgrenska University Hospital · SESwedish Armed Forces · SEUniversity of Gothenburg · SEUniversity of Turin · IT

Funding

Region Västra Götaland ALFGBG-725361Region Västra Götaland VGFOUREG-929979Sahlgrenska University Hospital 2020-02518
6 · The paper itself

Abstract

The global emergence of extended-spectrum beta-lactamase-producing

Indexed as

E. coliESBLextended-spectrum beta-lactamaserecurrent urinary tract infectionST131 subclade C2UTIwhole genome sequencing

Identifiers

PMID37512795
PMCPMC10384980
OpenAlexW4381663508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.